Font Size: a A A
Keyword [Programmed Death-1]
Result: 61 - 80 | Page: 4 of 5
61. The Impact Of LKB1 On PD-1 Blockade Therapy In Non-small Cell Lung Cancer
62. Identification And Characterization Of Nanobodies Binding With Programmed Death 1
63. Expression And Clinical Significance Of Negative Co-stimulatory Molecules SPD-1 And SPD-L1 In Ascites Of Patients With Hepatocellular Carcinoma
64. The Clinical Significance And The Expression Of Negative Costimulatory Molecule PD-1 And Its Ligand PD-L1 In Peripheral Blood Of Myasthenia Gravis Patients
65. Im Of PD-1/PD-L1?CTLA-4?TIGIT Expression Level And Clinical Significance
66. Expression And Clinical Significance Of LAG-3?PD-1 And HIF-1? In Non-small Cell Lung Cancer
67. The Difference Of Expression And Prognostic Value Of PD-1/PD-L1 Before And After Neoadiuvant Chemotherapy In Breast Carcinomas
68. Clinical Significance Of Programmed Death-1 And Programmed Death-ligand 1 Expression In Patients With Laryngeal And Hypopharyngeal Squamous Cell Carcinoma
69. Expression And Clicnical Significance Of TIM-3 And PD-1 In Breast Invasive Ductal Carcinoma Patients
70. Study On The SPD-1/sPD-L1 And Th1/Th2 And T17/Treg Related Cytokine In Patients With Primary Immune Thrombocytopenia
71. The Incidence And Risk Factors Of Pneumonitis In Patients Treated With Immune Checkpoint Inhibitors
72. Expression And Significance Of PD-1 On CD4+and CD8+T Cells In Tumor Tissues And Adjacent Tissues Of NCSLC
73. Expression And Mechanism Of PD-1/PD-L1 And Treg In JAK2 V617F-positive Myeloproliferative Neoplasms
74. Indirect Comparison Between Immune Checkpoint Inhibitors And Immune Checkpoint Inhibitors Plus Chemotherapy As First-line Treatment For Advanced Non-small Cell Lung Cancer:A Systematic Review
75. FGFR2 Promotes Expression Of PD-L1 In Colorectal Cancer Via The JAK-STAT3 Signaling Pathway
76. The Regulation And Function Of Programmed Death-1 In T-cell Acute Lymphoblastic Leukemia
77. The Mechanism And Evaluation Of The Combination Therapy Of Cryoablation And PD-1 Blockade In A Murine Model Of Renal Cell Carcinoma
78. Combination Of Fractionated Radiotherapy And Programmed Death-1 Monoclonal Antibody Blockade In The Treatment Of Lymphoma In Mice
79. Investigation On TCM Syndrome And Constitution Of Endometrial Polyp And The Immune Microenvironment Of Endometrial Polyps Based On PD-1/PD-L1
80. Expression And Clinical Significance Of PD1,PD-L1,MPIG6B,MEF2C And WDR1 In Children With ITP
  <<First  <Prev  Next>  Last>>  Jump to